ValuationViz

TVTX fund manager activity

Travere Therapeutics, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q4 2020 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementTrimmed15,849$900,4010.00%Aug 4, 2026
Joel Greenblatt - Gotham Asset ManagementTrimmed27,628$1,569,5470.00%Aug 14, 2026
Polen Capital ManagementNew34,315$1,949,4350.02%Aug 4, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementNo change33,996$1,010,0230.00%May 5, 2026
Joel Greenblatt - Gotham Asset ManagementTrimmed28,377$843,0810.00%May 15, 2026

Older quarters